Amicogen
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
64 Dongburo 1259, Chinju, Gyeongsangnam,...Phone Number
+82 557596161Website
www.amicogen.comRevenue
$83.2 MillionStock Symbol
092040Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Amicogen
Amicogen Inc is a company that operates in the Research & Development industry. It employs 100to249 people and has 50Mto100M of revenue. The company is headquartered in Chinju, Gyeongsangnam, South Korea.Explore more
Amicogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amicogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Amicogen has recently received funding, and reach out quickly before it becomes old news!
Amicogen, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Amicogen
Check out if Amicogen is spiking on competitors!
Click to see if Amicogen had a recent Job posting/layoffs
Product Launch: Get notified when Amicogen launches new products
Funding: Get notified immidiatlly once Amicogen has new funding data
Earning: See what the market has to say on Amicogen recently announced quarterly report
Recommended Actions
Find VP level buyers at Amicogen
Find 3 more new buyers
Company Profile Activity
Activity Insights
Amicogen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amicogen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amicogen.
Amicogen Tech Stack
A closer look at the technologies used by Amicogen
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
will be attending the Vitafoods Europe 2024 conference as an exhibitor. The event will occur from May 14 to May 16, 2024.
Events
Event
will be attending the Vitafoods Europe 2023 conference as an exhibitor. The event will occur from May 9 to May 11, 2023.
Event
Amicogen News & Media
Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #Artilysin--Amicogen, a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech company with expertise in the development of antimicrobial Artilysin®, to address the rising issue of mastitis in dairy cows caused by multi-resistant bacteria. According to recent research, the overuse of antibiotics in animal husbandry has been driving a fast increase in multidrug-resisLysando AG and Amicogen Inc. Sign General Development Agreement
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #UTI--Lysando AG – market leader in the field of antimicrobial proteins – has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South Korea. In August last year, Lysando and Amicogen entered into a strategic partnership backed up by a mutual participation model. This collaboration has since been further intensified, now culminating in aforementioned general development agreemeResumen: AMICOGEN Inc. y Lysando AG llevarán su acuerdo al siguiente nivel con participaciones en ambas empresas
BALZERS, Liechtenstein & JINJU, Corea del Sur--(BUSINESS WIRE)--AMICOGEN Inc., la empresa surcoreana que cotiza en KOSDAQ, se convertirá en el último accionista de Lysando AG. La operación incluye la adquisición de acciones, una contraprestación en efectivo para Lysando y un paquete de acciones de AMICOGEN para Lysando. El acuerdo supone un 8 % de la participación de AMICOGEN en Lysando y un 2,69 % en acciones de AMICOGEN para Lysando. Se negociaron las operaciones conAMICOGEN Inc. und Lysando AG bauen Partnerschaft zu gegenseitigem Beteiligungsmodell aus
BALZERS, Liechtenstein & JINJU, Südkorea--(BUSINESS WIRE)--Die im südkoreanischen Aktienindex KOSDAQ gelistete AMICOGEN Inc. wird neuer Aktionär der Lysando AG. Die Transaktion beinhaltet sowohl einen direkten Anteilserwerb, eine Barzahlung an die Lysando, als auch eine Beteiligung der Lysando an der AMICOGEN. AMICOGEN wird künftig mit 8% an der Lysando beteiligt sein, umgekehrt hält die Lysando 2,69% an der AMICOGEN. Die Transaktion wurde auf der Basis einer Bewertung von 300 Millionen Euro fü
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Amicogen
Sign Up For FreeTo access detailed company insights
Amicogen Inc is a company that operates in the Research & Development industry. It employs 100to249 people and has 50Mto100M of revenue. The company is headquartered in Chinju, Gyeongsangnam, South Korea.... Read More
